ATE285417T1 - Herstellung von antikörpern - Google Patents

Herstellung von antikörpern

Info

Publication number
ATE285417T1
ATE285417T1 AT96935109T AT96935109T ATE285417T1 AT E285417 T1 ATE285417 T1 AT E285417T1 AT 96935109 T AT96935109 T AT 96935109T AT 96935109 T AT96935109 T AT 96935109T AT E285417 T1 ATE285417 T1 AT E285417T1
Authority
AT
Austria
Prior art keywords
antibodies
selected part
source
immunizing
administering
Prior art date
Application number
AT96935109T
Other languages
English (en)
Inventor
Arthur Randell Bradwell
Original Assignee
Binding Site Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9522554.6A external-priority patent/GB9522554D0/en
Priority claimed from GBGB9615578.3A external-priority patent/GB9615578D0/en
Application filed by Binding Site Ltd filed Critical Binding Site Ltd
Application granted granted Critical
Publication of ATE285417T1 publication Critical patent/ATE285417T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96935109T 1995-11-03 1996-10-30 Herstellung von antikörpern ATE285417T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9522554.6A GB9522554D0 (en) 1995-11-03 1995-11-03 Improvements in and relating to the production of antibodies and test kits incorporating them
GBGB9615578.3A GB9615578D0 (en) 1996-07-24 1996-07-24 Improvements in and relating to the treatment of disorders which require the administration of substances which elicit an immune response
PCT/GB1996/002638 WO1997017372A1 (en) 1995-11-03 1996-10-30 Production of antibodies, and medical uses involving antibodies

Publications (1)

Publication Number Publication Date
ATE285417T1 true ATE285417T1 (de) 2005-01-15

Family

ID=26308046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96935109T ATE285417T1 (de) 1995-11-03 1996-10-30 Herstellung von antikörpern

Country Status (8)

Country Link
US (1) US8133744B1 (de)
EP (1) EP0862584B1 (de)
JP (1) JP4053596B2 (de)
AT (1) ATE285417T1 (de)
AU (1) AU7320096A (de)
DE (1) DE69634092T2 (de)
ES (1) ES2233980T3 (de)
WO (1) WO1997017372A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862584B1 (de) 1995-11-03 2004-12-22 The Binding Site Limited Herstellung von antikörpern
JP5634008B2 (ja) * 2004-04-06 2014-12-03 アフィボディ・アーベー 新規の使用および方法
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
GB0914535D0 (en) 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001950D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201001946D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB2478520A (en) 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201004442D0 (en) 2010-03-17 2010-05-05 Binding Site Group The Biomarker
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201117172D0 (en) 2011-10-05 2011-11-16 Binding Site Group The Ltd Diabetes
GB201121265D0 (en) 2011-12-12 2012-01-18 Binding Site Group The Ltd Assay
GB201603291D0 (en) 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
GB201708262D0 (en) 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease
JP6982226B2 (ja) 2017-07-06 2021-12-17 日東紡績株式会社 抗ヒトＩｇＧ４モノクローナル抗体、およびその抗体を利用したヒトＩｇＧ４測定試薬
WO2020229794A1 (en) 2019-05-10 2020-11-19 The Binding Site Group Limited Mass spectrometry calibrator
GB201906599D0 (en) 2019-05-10 2019-06-26 Binding Site Group Ltd Mass spectrometry calibrator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587193A (en) 1976-08-25 1981-04-01 Univ Birmingham Process for preparation of antisera
WO1988002594A2 (en) * 1986-10-09 1988-04-21 Neorx Corporation Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
EP0862584B1 (de) 1995-11-03 2004-12-22 The Binding Site Limited Herstellung von antikörpern

Also Published As

Publication number Publication date
DE69634092T2 (de) 2005-12-08
DE69634092D1 (de) 2005-01-27
AU7320096A (en) 1997-05-29
JP4053596B2 (ja) 2008-02-27
ES2233980T3 (es) 2005-06-16
US8133744B1 (en) 2012-03-13
EP0862584B1 (de) 2004-12-22
WO1997017372A1 (en) 1997-05-15
JP2001501579A (ja) 2001-02-06
EP0862584A1 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
ATE285417T1 (de) Herstellung von antikörpern
PT752876E (pt) Anticorpos monoclonicos que se conectam com o percursor antigeneo de rejeicao de tumores mage-1, mage-1 recombinante, e peptidos imunogenicos derivados de mage-1
DE69733960D1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DK0865448T4 (da) Apoptose induceret af monoklonalt antistof anti-Her2
DE69429095D1 (de) Humanisierte antikoerper
ATE153695T1 (de) Verfahren zur herstellung von antikörpern
DE69529649T2 (de) Anti-egfr einkettige fvs und anti-egfr antikoerper
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
DE68924773D1 (de) Monoklonale antikörper gegen den bereich der leichten kette von menschlichem faktor xii sowie methoden zu deren herstellung und verwendung.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
JPS6463393A (en) Monoclonal antibody
DE3650032D1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
SE8103198L (sv) Forfarande for framstellning av antikroppar
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ATE123066T1 (de) Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.
FI885169A0 (fi) Monoklonaalinen vasta-aine, joka tunnistaa N-asetyylineuramiinihapon -järjestyksessä, sen käyttö ja sitä tuottava hybridooma
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
ATE125305T1 (de) Monoklonale antikörper von ratten gegen menschliche antigene und verfahren zu deren herstellung.
WO2003016353A1 (en) Anti-ciguatoxin monoclonal antibody
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
Tsunoo et al. Effect of haptoglobin on immunological activity of hemoglobin
KR960701987A (ko) 단일클론 항체 88bv59, 서브클론 및 이들의 제조 방법(monoclonal antibody 88bv59, subclones and method of making)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties